10x Genomics (TXG) Financial Statements & Analysis

10x Genomics (TXG) Income Statement

10x Genomics reported revenue of $642.82M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 5.2% from $610.78M a year earlier. 10x Genomics posted a net loss of $43.54M, compared with a net loss of $182.63M a year earlier. Gross margin was 69.1% and operating margin -9.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $151.04M, down 12.6% from the same quarter a year earlier.

10x Genomics Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

10x Genomics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	642.82	610.79	618.73	516.41	490.49	298.85	245.89	146.31	71.09
Cost of Revenue	198.44	196.30	209.41	120.09	74.09	58.47	61.03	28.66	10.56
Gross Profit	443.88	414.48	409.31	396.02	416.40	240.38	184.86	117.65	60.53
Operating Expenses
Research & Development	234.53	264.70	265.73	264.27	211.75	123.38	83.10	47.54	32.16
Selling, General & Administrative	310.13	344.34	343.33	295.80	257.56	202.33	130.83	87.94	46.74
Operating Expenses	604.67	609.04	674.64	563.97	469.31	325.70	213.93	135.47	78.90
Operating Income	-60.99	-194.56	-265.33	-167.94	-52.91	-85.32	-29.07	-110.76	-18.38
Other Income/Expense
Interest Income	20.05	18.45	16.89	6.65	0.21	1.53	2.81	1.02	0.31
Interest Expense	0.00	0.00	-0.03	-0.48	0.87	1.68	3.08	2.41	0.81
Other Income/Expense	21.08	16.86	16.57	5.97	-0.80	-449.15	-1.96	-1.63	-0.37
Income
Income Before Tax	-39.91	-177.70	-248.76	-161.97	-53.72	-534.48	-31.03	-112.40	-18.74
Income Tax Expense	3.64	4.93	6.34	4.03	4.51	8.26	0.22	0.09	0.02
Net Income	-43.54	-182.63	-255.10	-166.00	-58.22	-542.73	-31.25	-112.49	-18.76
Net Income - Continuous Operations	-43.54	-182.63	-255.10	-166.00	-58.22	-542.73	-31.25	-112.49	-18.76
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	-64.09	-133.99	-164.24	-138.38	-24.60	-513.77	-20.89	-106.08	-13.63
EBIT	-100.29	-177.70	-199.75	-163.74	-52.91	-	-	-	-
Depreciation & Amortization	36.20	43.71	35.51	25.37	28.25	19.02	7.07	3.91	4.31
Earnings Per Share
Basic EPS	-	-2.00	-2.00	-1.00	-1.00	-5.00	-1.00	-8.00	-2.00
Diluted EPS	-	-2.00	-2.00	-1.00	-1.00	-5.00	-1.00	-8.00	-2.00
Basic Shares Outstanding	124.75	120.45	117.17	113.86	110.35	101.15	39.06	13.39	11.59
Diluted Shares Outstanding	124.75	120.45	117.17	113.86	110.35	101.15	39.09	13.39	11.59

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About 10x Genomics Financial Statements

What was 10x Genomics's revenue in fiscal 2025?

10x Genomics reported revenue of $642.82M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 5.2% from $610.78M a year earlier.

Is 10x Genomics profitable?

No. 10x Genomics reported a net loss of $43.54M in fiscal 2025. In fiscal 2024 it lost $182.63M.

What is 10x Genomics's operating margin?

10x Genomics's operating income was −$60.98M on revenue of $642.82M in fiscal 2025, an operating margin of -9.5%, compared with -31.9% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition